Biopharmaceutical
Development
Cancer
Treatment
Usa
Unitedstates
Medical
Conditions
M&A Advisory
Lazard
Full Credential Description
GTx. United States. Announced Date 27/10/2010. Closed Date 01/11/2010. Deal value: $40m. Underwritten registered direct offering of common stock. Industry: GTx is a biopharmaceutical company focused on the development of small molecules for the treatment of cancer and other serious medical conditions.